You have full text access to this OnlineOpen article

e-SPC – delivering drug information in the 21st century: developing new approaches to deliver drug information to prescribers

  1. Simon Maxwell1,*,
  2. Hans-Georg Eichler2,
  3. Anna Bucsics3,
  4. Walter E. Haefeli4,
  5. Lars L. Gustafsson5,
  6. the e-SPC Consortium†

Article first published online: 8 DEC 2011

DOI: 10.1111/j.1365-2125.2011.03981.x

Issue

British Journal of Clinical Pharmacology

British Journal of Clinical Pharmacology

Volume 73, Issue 1, pages 12–15, January 2012

Additional Information

How to Cite

Maxwell, S., Eichler, H.-G., Bucsics, A., Haefeli, W. E., Gustafsson, L. L. and the e-SPC Consortium (2012), e-SPC – delivering drug information in the 21st century: developing new approaches to deliver drug information to prescribers. British Journal of Clinical Pharmacology, 73: 12–15. doi: 10.1111/j.1365-2125.2011.03981.x

Author Information

  1. 1

    University of Edinburgh, Edinburgh, UK

  2. 2

    European Medicines Agency, London, UK

  3. 3

    Hauptverband d. Österr. Sozialversicherungsträger, Vienna, Austria

  4. 4

    University of Heidelberg, Heidelberg, Germany

  5. 5

    Karolinska Institute, Stockholm, Sweden

  1. †

    Members of the e-SPC Consortium: Anna Bucsics, Astrid Schoelzky, Almud Körbler (Hauptverband d. Österr. Sozialversicherungsträger, Vienna, Austria), Robert Vander Stichele (University Hospital of Gent, Belgium), Eric Van Ganze (Hopital Neurologique Pierre Wertheimer, France), Harald Herholz, Oliver Bültmann (GAIA AG, Hamburg, Germany), Walter Emil Haefeli, Hanna M Seidling, David Czock (Department of Clinical Pharmacology and Pharmacoepidemiology, University Hospital, Heidelberg, Germany), Klaus Menges (Federal Institute for Drugs and Medical Devices Division, Germany), Leonora Grandia (Royal Dutch Association for the Advancement of Pharmacy, the Netherlands), Jan Jakob Bekeringh, Marie-Louise van der Oppenraay (CVZ Organization of Dutch healthcare Insurance, the Netherlands), Steinar Madsen, Eirik Nikolai Arnesen (Norwegian Medical Products Agency and University Hospital, Oslo, Norway), Fernando Fernandez-Llimos, Blanca Argüello Magaz (University of Lisbon, Portugal), Lars L Gustafsson, Magnus Gruvén, Seher Korkmaz, Birgit Eiermann, Aniko Veg, Pia Bastholm, Brian Godman, Daniel Rodriguez, Paul Cohen, Anders Helldén, Birger Winbladh (Karolinska Institutet and Stockholm Healthcare Region, Stockholm, Sweden), Simon Maxwell (University of Edinburgh, UK), Magnus Gruvén, Hans-Georg Eichler, Hans-Georg Wagner, Peter Arlett, Laurent Brassart, Johan Holmgren, Juan Antonio Rueda Montes, Göran Isaksson, Tim Buxton (European Medicines Agency).

*Prof. Simon Maxwell MD, PhD, FRCP, FRCPE, FBPharmacolS, FHEA, Clinical Pharmacology Unit, University of Edinburgh, Clinical Research Centre, Western General Hospital, Edinburgh EH4 2XU, UK. Tel.: +44 131 537 1826. E-mail: s.maxwell@ed.ac.uk

  1. Disclaimer: The views expressed in this article are the personal views of the author(s) and may not be understood or quoted as being made on behalf of or reflecting the position of the European Medicines Agency, the Main Association of Austrian Social Security Institutions or one of their committees or working parties.

  2. †

    Members of the e-SPC Consortium: Anna Bucsics, Astrid Schoelzky, Almud Körbler (Hauptverband d. Österr. Sozialversicherungsträger, Vienna, Austria), Robert Vander Stichele (University Hospital of Gent, Belgium), Eric Van Ganze (Hopital Neurologique Pierre Wertheimer, France), Harald Herholz, Oliver Bültmann (GAIA AG, Hamburg, Germany), Walter Emil Haefeli, Hanna M Seidling, David Czock (Department of Clinical Pharmacology and Pharmacoepidemiology, University Hospital, Heidelberg, Germany), Klaus Menges (Federal Institute for Drugs and Medical Devices Division, Germany), Leonora Grandia (Royal Dutch Association for the Advancement of Pharmacy, the Netherlands), Jan Jakob Bekeringh, Marie-Louise van der Oppenraay (CVZ Organization of Dutch healthcare Insurance, the Netherlands), Steinar Madsen, Eirik Nikolai Arnesen (Norwegian Medical Products Agency and University Hospital, Oslo, Norway), Fernando Fernandez-Llimos, Blanca Argüello Magaz (University of Lisbon, Portugal), Lars L Gustafsson, Magnus Gruvén, Seher Korkmaz, Birgit Eiermann, Aniko Veg, Pia Bastholm, Brian Godman, Daniel Rodriguez, Paul Cohen, Anders Helldén, Birger Winbladh (Karolinska Institutet and Stockholm Healthcare Region, Stockholm, Sweden), Simon Maxwell (University of Edinburgh, UK), Magnus Gruvén, Hans-Georg Eichler, Hans-Georg Wagner, Peter Arlett, Laurent Brassart, Johan Holmgren, Juan Antonio Rueda Montes, Göran Isaksson, Tim Buxton (European Medicines Agency).

Publication History

  1. Issue published online: 8 DEC 2011
  2. Article first published online: 8 DEC 2011
  3. Accepted manuscript online: 6 APR 2011 07:43AM EST
  4. RECEIVED; 4 January 2011; ACCEPTED; 22 March 2011; ACCEPTED ARTICLE; 6 April 2011

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS